Acute granulocyte macrophage-colony stimulating factor treatment modulates neuroinflammatory processes and promotes tactile recovery after spinal cord injury-Reference-Cited by-同舟云学术

Acute granulocyte macrophage-colony stimulating factor treatment modulates neuroinflammatory processes and promotes tactile recovery after spinal cord injury

Published:2017-05 Issue: Volume:349 Page:144-164
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Thomaty Sandie,Pezard Laurent,Xerri Christian,Brezun Jean-Michel

Funder

Ministère de l'Enseignement Supérieur et de la Recherche

CNRS

Publisher

Elsevier BV

Subject

General Neuroscience

Reference121 articles.

1. Spasticity after spinal cord injury;Adams;Spinal cord,2005

2. Rho-Kinase/ROCK: a key regulator of the cytoskeleton and cell polarity;Amano;Cytoskelet Hoboken Nj,2010

3. White matter involvement after TBI: clues to axon and myelin repair capacity;Armstrong;Exp Neurol,2016

4. Free-D: an integrated environment for three-dimensionalreconstruction from serial sections;Andrey;J Neurosci Methods,2005

5. Altering spinal cord excitability enables voluntary movements after chronic complete paralysis in humans;Angeli;Brain J Neurol,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological management of secondary chronic spinal cord injury: a systematic review;British Medical Bulletin;2024-09-02

2. Granulocyte- Macrophage Colony-Stimulating Factor Reverses Immunosuppression Acutely Following a Traumatic Brain Injury and Hemorrhage Polytrauma in a Juvenile Male Rat Model;Journal of Neurotrauma;2024-07-01

3. Combined effect of trifluoperazine and sodium cromoglycate on reducing acute edema and limiting lasting functional impairments after spinal cord injury in rats;Experimental Neurology;2024-02

4. Granulocyte colony-stimulating factor effects on neurological and motor function in animals with spinal cord injury: a systematic review and meta-analysis;Frontiers in Neuroscience;2023-06-28

5. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders;Frontiers in Immunology;2023-01-05